We aimed to identify the candidate prostate cancer patients suitable for neoadjuvant androgen-deprivation therapy (ADT) with radical prostatectomy (RP).
This study included 711 Japanese patients with clinically localized prostate cancer who were treated with RP between 2000 and 2013.